 | • レポートコード：D0GIR-00822 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオシミラー試験・開発サービスの世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオシミラー試験・開発サービスの種類別市場規模（エフェクター結合、ELISA（エライザ）、速度論的結合アッセイ、ADCC・CDC細胞ベースアッセイ）、用途別市場規模（PKアッセイ、段階的免疫原性試験、NAbアッセイ）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Eurofins Scientific、Medistri、Pharmaceutical Product Development、SGS、Intertek Group、Charles River Laboratories、Sigma-Aldrich、Source BioScience、Exova、Pace Analytical Services ・地域別グローバル市場分析 2015年-2020年 ・バイオシミラー試験・開発サービスの北米市場（アメリカ、カナダ、メキシコ） ・バイオシミラー試験・開発サービスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオシミラー試験・開発サービスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオシミラー試験・開発サービスの南米市場（ブラジル、アルゼンチン） ・バイオシミラー試験・開発サービスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：エフェクター結合、ELISA（エライザ）、速度論的結合アッセイ、ADCC・CDC細胞ベースアッセイ ・用途別分析：PKアッセイ、段階的免疫原性試験、NAbアッセイ ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Biosimilar Testing and Development Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Biosimilar Testing and Development Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biosimilar Testing and Development Services market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biosimilar Testing and Development Services market has been segmented into:
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
By Application, Biosimilar Testing and Development Services has been segmented into:
PK assay
Tiered Immunogenicity testing
NAb assays
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilar Testing and Development Services market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilar Testing and Development Services markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilar Testing and Development Services market.
The report offers in-depth assessment of the growth and other aspects of the Biosimilar Testing and Development Services market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biosimilar Testing and Development Services Market Share Analysis
Biosimilar Testing and Development Services competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biosimilar Testing and Development Services sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilar Testing and Development Services sales, revenue and market share for each player covered in this report.
The major players covered in Biosimilar Testing and Development Services are:
Eurofins Scientific
Medistri
Pharmaceutical Product Development
SGS
Intertek Group
Charles River Laboratories
Sigma-Aldrich
Source BioScience
Exova
Pace Analytical Services
Table of Contents
1 Biosimilar Testing and Development Services Market Overview
1.1 Product Overview and Scope of Biosimilar Testing and Development Services
1.2 Classification of Biosimilar Testing and Development Services by Type
1.2.1 Global Biosimilar Testing and Development Services Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biosimilar Testing and Development Services Revenue Market Share by Type in 2019
1.2.3 Effector Binding
1.2.4 ELISA
1.2.5 Kinetic Binding Assays
1.2.6 ADCC & CDC Cell-Based Assays
1.3 Global Biosimilar Testing and Development Services Market by Application
1.3.1 Overview: Global Biosimilar Testing and Development Services Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Global Biosimilar Testing and Development Services Market by Regions
1.4.1 Global Biosimilar Testing and Development Services Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biosimilar Testing and Development Services (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biosimilar Testing and Development Services Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biosimilar Testing and Development Services Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimilar Testing and Development Services Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biosimilar Testing and Development Services Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimilar Testing and Development Services Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eurofins Scientific
2.1.1 Eurofins Scientific Details
2.1.2 Eurofins Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eurofins Scientific SWOT Analysis
2.1.4 Eurofins Scientific Product and Services
2.1.5 Eurofins Scientific Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.2 Medistri
2.2.1 Medistri Details
2.2.2 Medistri Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Medistri SWOT Analysis
2.2.4 Medistri Product and Services
2.2.5 Medistri Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pharmaceutical Product Development
2.3.1 Pharmaceutical Product Development Details
2.3.2 Pharmaceutical Product Development Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pharmaceutical Product Development SWOT Analysis
2.3.4 Pharmaceutical Product Development Product and Services
2.3.5 Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.4 SGS
2.4.1 SGS Details
2.4.2 SGS Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 SGS SWOT Analysis
2.4.4 SGS Product and Services
2.4.5 SGS Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.5 Intertek Group
2.5.1 Intertek Group Details
2.5.2 Intertek Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Intertek Group SWOT Analysis
2.5.4 Intertek Group Product and Services
2.5.5 Intertek Group Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.6 Charles River Laboratories
2.6.1 Charles River Laboratories Details
2.6.2 Charles River Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Charles River Laboratories SWOT Analysis
2.6.4 Charles River Laboratories Product and Services
2.6.5 Charles River Laboratories Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sigma-Aldrich
2.7.1 Sigma-Aldrich Details
2.7.2 Sigma-Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sigma-Aldrich SWOT Analysis
2.7.4 Sigma-Aldrich Product and Services
2.7.5 Sigma-Aldrich Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.8 Source BioScience
2.8.1 Source BioScience Details
2.8.2 Source BioScience Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Source BioScience SWOT Analysis
2.8.4 Source BioScience Product and Services
2.8.5 Source BioScience Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.9 Exova
2.9.1 Exova Details
2.9.2 Exova Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Exova SWOT Analysis
2.9.4 Exova Product and Services
2.9.5 Exova Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pace Analytical Services
2.10.1 Pace Analytical Services Details
2.10.2 Pace Analytical Services Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pace Analytical Services SWOT Analysis
2.10.4 Pace Analytical Services Product and Services
2.10.5 Pace Analytical Services Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biosimilar Testing and Development Services Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biosimilar Testing and Development Services Players Market Share
3.2.2 Top 10 Biosimilar Testing and Development Services Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biosimilar Testing and Development Services Revenue and Market Share by Regions
4.2 North America Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
4.3 Europe Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
4.5 South America Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
5 North America Biosimilar Testing and Development Services Revenue by Countries
5.1 North America Biosimilar Testing and Development Services Revenue by Countries (2015-2020)
5.2 USA Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
5.3 Canada Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
5.4 Mexico Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
6 Europe Biosimilar Testing and Development Services Revenue by Countries
6.1 Europe Biosimilar Testing and Development Services Revenue by Countries (2015-2020)
6.2 Germany Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
6.3 UK Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
6.4 France Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
6.5 Russia Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
6.6 Italy Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biosimilar Testing and Development Services Revenue by Countries
7.1 Asia-Pacific Biosimilar Testing and Development Services Revenue by Countries (2015-2020)
7.2 China Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
7.3 Japan Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
7.4 Korea Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
7.5 India Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
8 South America Biosimilar Testing and Development Services Revenue by Countries
8.1 South America Biosimilar Testing and Development Services Revenue by Countries (2015-2020)
8.2 Brazil Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
8.3 Argentina Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biosimilar Testing and Development Services by Countries
9.1 Middle East & Africa Biosimilar Testing and Development Services Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
9.3 UAE Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
9.4 Egypt Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
9.5 South Africa Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biosimilar Testing and Development Services Revenue and Market Share by Type (2015-2020)
10.2 Global Biosimilar Testing and Development Services Market Forecast by Type (2019-2024)
10.3 Effector Binding Revenue Growth Rate (2015-2025)
10.4 ELISA Revenue Growth Rate (2015-2025)
10.5 Kinetic Binding Assays Revenue Growth Rate (2015-2025)
10.6 ADCC & CDC Cell-Based Assays Revenue Growth Rate (2015-2025)
11 Global Biosimilar Testing and Development Services Market Segment by Application
11.1 Global Biosimilar Testing and Development Services Revenue Market Share by Application (2015-2020)
11.2 Biosimilar Testing and Development Services Market Forecast by Application (2019-2024)
11.3 PK assay Revenue Growth (2015-2020)
11.4 Tiered Immunogenicity testing Revenue Growth (2015-2020)
11.5 NAb assays Revenue Growth (2015-2020)
12 Global Biosimilar Testing and Development Services Market Size Forecast (2021-2025)
12.1 Global Biosimilar Testing and Development Services Market Size Forecast (2021-2025)
12.2 Global Biosimilar Testing and Development Services Market Forecast by Regions (2021-2025)
12.3 North America Biosimilar Testing and Development Services Revenue Market Forecast (2021-2025)
12.4 Europe Biosimilar Testing and Development Services Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biosimilar Testing and Development Services Revenue Market Forecast (2021-2025)
12.6 South America Biosimilar Testing and Development Services Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biosimilar Testing and Development Services Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biosimilar Testing and Development Services Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biosimilar Testing and Development Services by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimilar Testing and Development Services Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biosimilar Testing and Development Services Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eurofins Scientific Corporate Information, Location and Competitors
Table 6. Eurofins Scientific Biosimilar Testing and Development Services Major Business
Table 7. Eurofins Scientific Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 8. Eurofins Scientific SWOT Analysis
Table 9. Eurofins Scientific Biosimilar Testing and Development Services Product and Solutions
Table 10. Eurofins Scientific Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Medistri Corporate Information, Location and Competitors
Table 12. Medistri Biosimilar Testing and Development Services Major Business
Table 13. Medistri Biosimilar Testing and Development Services Total Revenue (USD Million) (2018-2019)
Table 14. Medistri SWOT Analysis
Table 15. Medistri Biosimilar Testing and Development Services Product and Solutions
Table 16. Medistri Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pharmaceutical Product Development Corporate Information, Location and Competitors
Table 18. Pharmaceutical Product Development Biosimilar Testing and Development Services Major Business
Table 19. Pharmaceutical Product Development Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 20. Pharmaceutical Product Development SWOT Analysis
Table 21. Pharmaceutical Product Development Biosimilar Testing and Development Services Product and Solutions
Table 22. Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. SGS Corporate Information, Location and Competitors
Table 24. SGS Biosimilar Testing and Development Services Major Business
Table 25. SGS Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 26. SGS SWOT Analysis
Table 27. SGS Biosimilar Testing and Development Services Product and Solutions
Table 28. SGS Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Intertek Group Corporate Information, Location and Competitors
Table 30. Intertek Group Biosimilar Testing and Development Services Major Business
Table 31. Intertek Group Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 32. Intertek Group SWOT Analysis
Table 33. Intertek Group Biosimilar Testing and Development Services Product and Solutions
Table 34. Intertek Group Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Charles River Laboratories Corporate Information, Location and Competitors
Table 36. Charles River Laboratories Biosimilar Testing and Development Services Major Business
Table 37. Charles River Laboratories Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 38. Charles River Laboratories SWOT Analysis
Table 39. Charles River Laboratories Biosimilar Testing and Development Services Product and Solutions
Table 40. Charles River Laboratories Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sigma-Aldrich Corporate Information, Location and Competitors
Table 42. Sigma-Aldrich Biosimilar Testing and Development Services Major Business
Table 43. Sigma-Aldrich Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 44. Sigma-Aldrich SWOT Analysis
Table 45. Sigma-Aldrich Biosimilar Testing and Development Services Product and Solutions
Table 46. Sigma-Aldrich Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Source BioScience Corporate Information, Location and Competitors
Table 48. Source BioScience Biosimilar Testing and Development Services Major Business
Table 49. Source BioScience Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 50. Source BioScience SWOT Analysis
Table 51. Source BioScience Biosimilar Testing and Development Services Product and Solutions
Table 52. Source BioScience Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Exova Corporate Information, Location and Competitors
Table 54. Exova Biosimilar Testing and Development Services Major Business
Table 55. Exova Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 56. Exova SWOT Analysis
Table 57. Exova Biosimilar Testing and Development Services Product and Solutions
Table 58. Exova Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pace Analytical Services Corporate Information, Location and Competitors
Table 60. Pace Analytical Services Biosimilar Testing and Development Services Major Business
Table 61. Pace Analytical Services Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 62. Pace Analytical Services SWOT Analysis
Table 63. Pace Analytical Services Biosimilar Testing and Development Services Product and Solutions
Table 64. Pace Analytical Services Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Biosimilar Testing and Development Services Revenue (Million USD) by Players (2015-2020)
Table 66. Global Biosimilar Testing and Development Services Revenue Share by Players (2015-2020)
Table 67. Global Biosimilar Testing and Development Services Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Biosimilar Testing and Development Services Revenue Market Share by Regions (2015-2020)
Table 69. North America Biosimilar Testing and Development Services Revenue by Countries (2015-2020)
Table 70. North America Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Table 71. Europe Biosimilar Testing and Development Services Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Biosimilar Testing and Development Services Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Biosimilar Testing and Development Services Revenue by Countries (2015-2020)
Table 74. South America Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Biosimilar Testing and Development Services Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Table 77. Global Biosimilar Testing and Development Services Revenue (Million USD) by Type (2015-2020)
Table 78. Global Biosimilar Testing and Development Services Revenue Share by Type (2015-2020)
Table 79. Global Biosimilar Testing and Development Services Revenue Forecast by Type (2021-2025)
Table 80. Global Biosimilar Testing and Development Services Revenue by Application (2015-2020)
Table 81. Global Biosimilar Testing and Development Services Revenue Share by Application (2015-2020)
Table 82. Global Biosimilar Testing and Development Services Revenue Forecast by Application (2021-2025)
Table 83. Global Biosimilar Testing and Development Services Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biosimilar Testing and Development Services Picture
Figure 2. Global Biosimilar Testing and Development Services Revenue Market Share by Type in 2019
Figure 3. Effector Binding Picture
Figure 4. ELISA Picture
Figure 5. Kinetic Binding Assays Picture
Figure 6. ADCC & CDC Cell-Based Assays Picture
Figure 7. Biosimilar Testing and Development Services Revenue Market Share by Application in 2019
Figure 8. PK assay Picture
Figure 9. Tiered Immunogenicity testing Picture
Figure 10. NAb assays Picture
Figure 11. Global Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Biosimilar Testing and Development Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Biosimilar Testing and Development Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Biosimilar Testing and Development Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Biosimilar Testing and Development Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Biosimilar Testing and Development Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Biosimilar Testing and Development Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Biosimilar Testing and Development Services Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Biosimilar Testing and Development Services Revenue Market Share in 2019
Figure 20. Global Top 10 Players Biosimilar Testing and Development Services Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Biosimilar Testing and Development Services Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Biosimilar Testing and Development Services Revenue Market Share by Regions (2015-2020)
Figure 24. Global Biosimilar Testing and Development Services Revenue Market Share by Regions in 2018
Figure 25. North America Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 26. Europe Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 28. South America Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 30. North America Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Figure 31. North America Biosimilar Testing and Development Services Revenue Market Share by Countries in 2019
Figure 32. USA Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 33. Canada Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 35. Europe Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Biosimilar Testing and Development Services Revenue Market Share by Countries in 2019
Figure 37. Germany Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 38. UK Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 39. France Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 40. Russia Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 41. Italy Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Biosimilar Testing and Development Services Revenue Market Share by Countries in 2019
Figure 44. China Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 45. Japan Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 46. Korea Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 47. India Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 49. South America Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Figure 50. South America Biosimilar Testing and Development Services Revenue Market Share by Countries in 2019
Figure 51. Brazil Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Biosimilar Testing and Development Services Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 56. UAE Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2020)
Figure 59. Global Biosimilar Testing and Development Services Revenue Share by Type (2015-2020)
Figure 60. Global Biosimilar Testing and Development Services Revenue Share by Type in 2019
Figure 61. Global Biosimilar Testing and Development Services Market Share Forecast by Type (2021-2025)
Figure 62. Global Effector Binding Revenue Growth Rate (2015-2020)
Figure 63. Global ELISA Revenue Growth Rate (2015-2020)
Figure 64. Global Kinetic Binding Assays Revenue Growth Rate (2015-2020)
Figure 65. Global ADCC & CDC Cell-Based Assays Revenue Growth Rate (2015-2020)
Figure 66. Global Biosimilar Testing and Development Services Revenue Share by Application (2015-2020)
Figure 67. Global Biosimilar Testing and Development Services Revenue Share by Application in 2019
Figure 68. Global Biosimilar Testing and Development Services Market Share Forecast by Application (2021-2025)
Figure 69. Global PK assay Revenue Growth Rate (2015-2020)
Figure 70. Global Tiered Immunogenicity testing Revenue Growth Rate (2015-2020)
Figure 71. Global NAb assays Revenue Growth Rate (2015-2020)
Figure 72. Global Biosimilar Testing and Development Services Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Biosimilar Testing and Development Services Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Biosimilar Testing and Development Services Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Biosimilar Testing and Development Services Revenue Market Forecast (2021-2025)
Figure 76. Europe Biosimilar Testing and Development Services Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Biosimilar Testing and Development Services Revenue Market Forecast (2021-2025)
Figure 78. South America Biosimilar Testing and Development Services Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Biosimilar Testing and Development Services Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
バイオシミラーモノクローナル抗体の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Biosimilar Monoclonal Antibody market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 26.5% in the forecast period of 2020 to 2025 and will expected to reach USD 12060 million by 2025, from USD 4706.7 million in 2019. The Biosi…- 検査・品質保証（QA）サービスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Testing and Quality Assurance (QA) Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…
- 細胞株開発の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cell Line Development market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 4264.6 million by 2025, from USD 3280 million in 2019. The Cell Line Develo…
- 生物学的安全性試験の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Biologics Safety Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.7% in the forecast period of 2020 to 2025 and will expected to reach USD 3287.6 million by 2025, from USD 2538.9 million in 2019. The Biologics S…
- M2Mアプリケーション開発プラットフォームの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The M2M Application Development Platform market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…